IDENTIFYING NOVEL COMPOUNDS FOR TREATMENT OF PDCHORDOMA AND OTHER SMARCB1-DEFICIENT RARE TUMORS

$472,251FY2025Defense Health AgencyDOD

Oregon Health & Science University, Portland OR

Investigators